Urol. praxi. 2025;26(4):217-219 | DOI: 10.36290/uro.2025.090

Rational approach to the treatment and prevention of lower urinary tract infections in women

MUDr. Marcela Fontana, Ph.D., FEBU, MUDr. Michaela Matoušková
Urocentrum Praha

Acute cystitis is the most common form of urinary tract infection (UTI), commonly treated by physicians across various specialties. The latest guidelines of the European Association of Urology introduce a new classification of UTIs into localized and syste­mic, replacing the previsous division into complicated and uncomplicated UTIs. They also emphasize the importance of antimicrobial stewardship and rational antibiotic use, considering potential adverse effects, the risc of insreasing bacterial resistance, and disruption of the patient's natural microbiome. The following text summarizes current recommendations regarding the treatment and prevention of acute cystitis in women.

Keywords: acute cystitis, recurrent cystitis, antibiotic therapy, prophylaxis.

Accepted: November 24, 2025; Published: December 16, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fontana M, Matoušková M. Rational approach to the treatment and prevention of lower urinary tract infections in women. Urol. praxi. 2025;26(4):217-219. doi: 10.36290/uro.2025.090.
Download citation

References

  1. Bonkat G, Kranz J, Cai T, et al. Urological Infections [Internet]. Arnhen: EAU Guidelines Office; 2025 [cited 2025 July 29]. Available from: https://uroweb.org/guidelines/urological-infections.
  2. Matoušková M, Adámková V, Fontana M. Infekce močových cest. In: Karel I, Jakubec P, Matoušková M, et al. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. Antibiotická terapie respiračních, močových a kožních infekcí v ordinaci všeobecného praktického lékaře. Antibiotická terapie - novelizace 2025. Praha: Společnost všeobecného lékařství ČLS JEP; 2025.
  3. Matoušková M, Adámková V, Čechová M, et al. Konsenzuální postupy v léčbě močových infekcí. 1. vydání. Olomouc: Solen Medical Education; 2022.
  4. Dlouhý P, Žemličková H, Štefan M, et al. Antibiotická léčba infekcí vyvolaných multirezistentními gramnegativními bakteriemi. [Internet]. 2021 [cited Jul 25]. Available from: https://www.splm.cz/_download/00000197-a064-dd43-add7-fb6616030000.
  5. National Institute for Health and Care Excellence (NICE), 2018. Urinary tract infection (lower): antimicrobial prescribing. [Internet]. NICE guideline [NG109]; 2018 [Cited 22 Aug. 2025]. Available from: https://www.nice.org.uk/guidance/ng109.
  6. Hooton TM, Vecchio M, Iroz A, et al. Y. Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial. JAMA Intern Med. 2018;178(11):1509-1515. Go to original source... Go to PubMed...
  7. Adatto K, Doebele KG, Galland L, et al. Behavioral factors and urinary tract infection. JAMA. 1979;241(23):2525-2526. Go to original source...
  8. Chen YY, Su TH, Lau HH. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials. Int Urogynecol J. 2021;32(1):17-25. Go to original source... Go to PubMed...
  9. Beerepoot MA, Geerlings SE, van Haarst EP, et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190(6):1981-1989. Go to original source... Go to PubMed...
  10. Mak Q, Greig J, Dasgupta P, et al. Bacterial Vaccines for the Management of Recurrent Urinary Tract Infections: A Systematic Review and Meta-analysis. Eur Urol Focus. 2024;10(5):761-769. Go to original source... Go to PubMed...
  11. Grin PM, Kowalewska PM, Alhazzan W, et al. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20(1):6607-6614.
  12. Ng QX, Peters C, Venkatanarayanan N, et al. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females. Med Hypotheses. 2018;114:49-54. Go to original source... Go to PubMed...
  13. Fu Z, Liska D, Talan D, et al. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J Nutr. 2017;147(12):2282-2288. Go to original source... Go to PubMed...
  14. Luís Â, Domingues F, Pereira L. Can Cranberries Contribute to Reduce the Incidence of Urinary Tract Infections? A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Clinical Trials. J Urol. 2017;198(3):614-621. Go to original source... Go to PubMed...
  15. Lenger SM, Bradley MS, Thomas DA, et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1-265.e13. Go to original source... Go to PubMed...
  16. Kranz J, Schmidt S, Schneidewind L. Current Evidence on Nonantibiotic Prevention of Recurrent Urinary Tract Infections. Eur Urol Focus. 2019;5(1):17-19. Go to original source... Go to PubMed...
  17. Cai T, Anceschi U, Tamanini I, et al. Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2021;11(1):14. Go to original source... Go to PubMed...
  18. Naber KG, Alidjanov JF, Fünfstück R, et al. FM. Therapeutic strategies for uncomplicated cystitis in women. GMS Infect Dis. 2024;12:Doc01.
  19. Damiano R, Quarto G, Bava I, et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol. 2011;59(4):645-651. Go to original source... Go to PubMed...
  20. De Vita D, Giordano S. Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study. Int Urogynecol J. 2012;23(12):1707-1713. Go to original source... Go to PubMed...
  21. Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung. 2005;55(7):420-427. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.